Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00409604
NCT00409604
Completed
Phase 2

Clinical Evaluation of Pacing During the Onset of Revascularization / Feasibility Study

Guidant Corporation1 site in 1 country60 target enrollmentDecember 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcute Myocardial Infarction

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
Guidant Corporation
Enrollment
60
Locations
1
Primary Endpoint
Infarct size (area under the curve of creatine kinase) at baseline compared with MRI at 4 months and at 12 months
Status
Completed
Last Updated
15 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction

Detailed Description

To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction

Registry
clinicaltrials.gov
Start Date
December 2006
End Date
August 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Clinical diagnosis of acute myocardial infarction, requiring PCI within 2 to 6 hours following symptoms
  • •Total occlusion of a coronary artery with reference vessel diameter \>or= 3mm

Exclusion Criteria

  • •Thrombolitics
  • •Severe bradycardia requiring cardiac pacing
  • •Previous PCI or CABG
  • •Recent stroke or CV surgery
  • •Recent major surgery or trauma
  • •Clinical and hemodynamic unstability
  • •Implanted CRM device
  • •Evidence of previous MI
  • •Diabetes using rosiglitazone or other fibrates
  • •Permanent AF

Outcomes

Primary Outcomes

Infarct size (area under the curve of creatine kinase) at baseline compared with MRI at 4 months and at 12 months

Time Frame: 4 & 12 months

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Assessing the implications of prophylactic permanent pacemaker implantation for patients undergoing Transcatheter Aortic Valve Implantation (TAVI)
ACTRN12620001175965A/Prof Dennis Lau30
Completed
Not Applicable
Neuromonitoring During Rapid Ventricular Pacing in Patients Undergoing Cerebral Aneurysm SurgeryCerebral Arterial AneurysmVentricular Rate Response Pacing
NCT03185091University Hospital, Antwerp7
Recruiting
Not Applicable
Clinical Study of LBBPBradyarrhythmiasHeart Failure
NCT04919447Second Affiliated Hospital, School of Medicine, Zhejiang University540
Completed
Not Applicable
Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic CardiomyopathyCardiomyopathy, Hypertrophic
NCT03450252Barts & The London NHS Trust17
Completed
Not Applicable
Ventricular Stimulation as Predictor of Hypovolemia After Cardiac SurgeryCardiac SurgeryHypovolemia
NCT03926910CMC Ambroise Paré30